JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M410868200 on December 8, 2004

J. Biol. Chem., Vol. 280, Issue 9, 8086-8093, March 4, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/9/8086    most recent
M410868200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerkmann, M.
Right arrow Articles by Hartmann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerkmann, M.
Right arrow Articles by Hartmann, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Spontaneous Formation of Nucleic Acid-based Nanoparticles Is Responsible for High Interferon-{alpha} Induction by CpG-A in Plasmacytoid Dendritic Cells*

Miren Kerkmann{ddagger}§, Lilian T. Costa¶||, Christine Richter{ddagger}, Simon Rothenfusser{ddagger}, Julia Battiany{ddagger}, Veit Hornung{ddagger}, Judith Johnson**, Steffen Englert{ddagger}{ddagger}, Thomas Ketterer§§, Wolfgang Heckl¶, Stefan Thalhammer¶||, Stefan Endres{ddagger}, and Gunther Hartmann{ddagger}¶¶

From the {ddagger}Department of Internal Medicine, Division of Clinical Pharmacology, Ludwig-Maximilians-University of Munich, 80336 Muenchen, Germany, Department of Geo- and Environment Sciences, Ludwig-Maximilians-University of Munich, 80333 Muenchen, Germany, **Institute of Immunology, Ludwig-Maximilians-University of Munich, 80336 Muenchen, Germany, §§CureVac GmbH, 72076 Tuebingen, Germany, and {ddagger}{ddagger}Research Center for Nucleic Acid and Peptide Chemistry, University of Tuebingen, 72076 Tuebingen, Germany

Plasmacytoid dendritic cells (PDC) represent a highly specialized immune cell subset that produces large quantities of the anti-viral cytokines type I interferons (IFN-{alpha} and IFN-{beta}) upon viral infection. PDC employ a member of the family of toll-like receptors, TLR9, to detect CpG motifs (unmethylated CG dinucleotides in certain base context) present in viral DNA. A certain group of CpG motif-containing oligodeoxynucleotides (CpG ODN), CpG-A, was the first synthetic stimulus available that induced large amounts of interferon-{alpha} (IFN-{alpha}) in PDC. However, the mechanism responsible for this activity remained elusive. CpG-A is characterized by a central palindrome and poly(G) at the 5' and 3' end. Here we demonstrate that CpG-A self-assembles to higher order tertiary structures via G-tetrad formation of their poly(G) motifs. Spontaneous G-tetrad formation of CpG-A required the palindrome sequence allowing structure formation in a physiological environment. Once formed, G-tetrad-linked structures were stable even under denaturing conditions. Atomic force microscopy revealed that the tertiary structures formed by CpG-A represent nucleic acid-based nanoparticles in the size range of viruses. Similarly sized preformed polystyrene nanoparticles loaded with a CpG ODN that is otherwise weak at inducing IFN-{alpha} (CpG-B) gained the potency of CpG-A to induce IFN-{alpha}. Higher ODN uptake in PDC was not responsible for the higher IFN-{alpha}-inducing activity of CpG-A or of CpG-B-coated nanoparticles as compared with CpG-B. Based on these results we propose a model in which the spatial configuration of CpG motifs as particle is responsible for the virus-like potency of CpG-A to induce IFN-{alpha} in PDC.


Received for publication, September 21, 2004 , and in revised form, December 3, 2004.

* This study was supported in part by a grant from the Bundesministerium für Bildung und Forschung (Biofuture 0311896), Deutsche Forschungsgemeinschaft Grants HA 2780/4-1 and SFB 571, Dr. Mildred Scheel Stiftung Grant 10-2074, and a grant from the Human Science Foundation of Japan (to G. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ This work is part of the dissertation of this author at the Ludwig-Maximilians-University of Munich.

|| Financially supported by the Deutscher Akademischer Austauschdienst and Deutsche Forschungsgemeinschaft Sonderforschungsbereich 486.

¶¶ To whom correspondence should be addressed: Abteilung für Klinische Pharmakologie, Medizinische Klinik Innenstadt, Klinikum der Ludwig-Maximilians-Universität München, Ziemssenstrasse 1, 80336 München, Germany. Tel.: 49-89-5160-2331; Fax: 49-89-5160-4406; E-mail: ghartmann{at}lrz.uni-muenchen.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Bourquin, D. Anz, K. Zwiorek, A.-L. Lanz, S. Fuchs, S. Weigel, C. Wurzenberger, P. von der Borch, M. Golic, S. Moder, et al.
Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity
J. Immunol., September 1, 2008; 181(5): 2990 - 2998.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Knuefermann, M. Schwederski, M. Velten, P. Krings, H. Ehrentraut, M. Rudiger, O. Boehm, K. Fink, U. Dreiner, C. Grohe, et al.
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9
Cardiovasc Res, April 1, 2008; 78(1): 26 - 35.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Shin, T. Toy, S. Rothenfusser, N. Robson, J. Vorac, M. Dauer, M. Stuplich, S. Endres, J. Cebon, E. Maraskovsky, et al.
P2Y receptor signaling regulates phenotype and IFN-{alpha} secretion of human plasmacytoid dendritic cells
Blood, March 15, 2008; 111(6): 3062 - 3069.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Magnusson, R. Tobes, J. Sancho, and E. Pareja
Cutting Edge: Natural DNA Repetitive Extragenic Sequences from Gram-Negative Pathogens Strongly Stimulate TLR9
J. Immunol., July 1, 2007; 179(1): 31 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. H. Wikstrom, B. M. Meehan, M. Berg, S. Timmusk, J. Elving, L. Fuxler, M. Magnusson, G. M. Allan, F. McNeilly, and C. Fossum
Structure-Dependent Modulation of Alpha Interferon Production by Porcine Circovirus 2 Oligodeoxyribonucleotide and CpG DNAs in Porcine Peripheral Blood Mononuclear Cells
J. Virol., May 15, 2007; 81(10): 4919 - 4927.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Puig, A. Grajkowski, M. Boczkowska, C. Ausin, S. L. Beaucage, and D. Verthelyi
Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates
Nucleic Acids Res., December 2, 2006; 34(22): 6488 - 6495.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
V. Hornung, J. Ellegast, S. Kim, K. Brzozka, A. Jung, H. Kato, H. Poeck, S. Akira, K.-K. Conzelmann, M. Schlee, et al.
5'-Triphosphate RNA Is the Ligand for RIG-I
Science, November 10, 2006; 314(5801): 994 - 997.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Jozefowski, T. H. Sulahian, M. Arredouani, and L. Kobzik
Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides
J. Leukoc. Biol., October 1, 2006; 80(4): 870 - 879.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Guiducci, G. Ott, J. H. Chan, E. Damon, C. Calacsan, T. Matray, K.-D. Lee, R. L. Coffman, and F. J. Barrat
Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation
J. Exp. Med., August 7, 2006; 203(8): 1999 - 2008.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Gursel, I. Gursel, H. S. Mostowski, and D. M. Klinman
CXCL16 Influences the Nature and Specificity of CpG-Induced Immune Activation
J. Immunol., August 1, 2006; 177(3): 1575 - 1580.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. S. Patole, D. Zecher, R. D. Pawar, H.-J. Grone, D. Schlondorff, and H.-J. Anders
G-Rich DNA Suppresses Systemic Lupus
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3273 - 3280.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Asselin-Paturel and G. Trinchieri
Production of type I interferons: plasmacytoid dendritic cells and beyond
J. Exp. Med., August 15, 2005; 202(4): 461 - 465.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.